Kreipe H, Zeidler R, Kneitz H, Feist H
Institut für Pathologie, Universität Würzburg.
Verh Dtsch Ges Pathol. 1994;78:36-7.
The highly proliferating phenotype of mammary carcinoma is known to be associated with a particularly aggressive clinical course. We have been interested in the underlying molecular causes that give rise to the increased proliferative activity Proliferative activity was determined immunohistochemically by the detection of topoisomerase II-alpha (Ki-S1). The subgroup of highly proliferating tumors with a Ki-S1 index exceeding 30% was characterized by a high frequency of c-myc amplification and aberrant p53 expression, whereas tumors, with a low mitotic activity rarely exhibited gene amplification or an altered p53 expression. We conclude, that the highly proliferating phenotype is not capable of regular replication and tends to develop gene amplifications. One of the causes might be a defective cell cycle control by p53.
已知乳腺癌的高增殖表型与特别侵袭性的临床病程相关。我们一直对导致增殖活性增加的潜在分子原因感兴趣。通过检测拓扑异构酶II-α(Ki-S1),采用免疫组织化学方法确定增殖活性。Ki-S1指数超过30%的高增殖肿瘤亚组的特征是c-myc扩增频率高和p53表达异常,而有丝分裂活性低的肿瘤很少表现出基因扩增或p53表达改变。我们得出结论,高增殖表型不能进行正常复制,并且倾向于发生基因扩增。原因之一可能是p53对细胞周期的控制存在缺陷。